A study for key biomarkers and new drug targets to represent the disease progression and clinical outcome of HIV infection
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Efavirenz/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 26 Feb 2016 Status changed from recruiting to completed.
- 21 Aug 2013 New trial record